Agree with you fully. This company needs to be sold with the best available deal now or soon. Somebody just reminds me of JT, trying to maximaize the share value? (How and when)...
Let us face it:
I think we have seen enough what this mgmt can do;
what is the next catalyst? None except Eu approval (I assume it is still one or not);
Amrn’s sale won’t take off
So there is not point waiting imo, period. The longer, the worse (possibly another round dilute). So let us hire a IB, admit failure of gia, and be honest about it, no more ruse, open for any offer for the benefits of share holder and cardiovascular patients, and then accept the best deal, if not good enough for somebody, I suggest them rethink what other options do we have, none. That is it.
News 
Market Data 
Discover 
AI
